POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES (11.19.2021, 4:50pm CEST, WHO):   India 11,106    Brazil 11,977    United Kingdom 46,858    Russia 37,156    Turkey 22,234    France 19,840    Argentina 1,553    Germany 52,970    Spain 3,932    Columbia 2,257    Italy 10,645    Mexico 3,836    Ukraine 20,050    Poland 23,242    Philippines 1,297    Malaysia 6,380    Netherlands 23,680    Peru 1,370    Thailand 6,855    Czechia 13,374    Canada 2,448    Romania 3,076    Chile 2,611    Serbia 3,219    Sweden 1,210    Portugal 2,398    Vietnam 10,223    Kazakhstan 1,272    Austria 14,212    Hungary 11,289    Greece 7,276    Georgia 4,278    Bulgaria 2,785    Belarus 1,844    Slovakia 7,418    Azerbaijan 2,124    Croatia 7,270    Bolivia 1,119    Ireland 4,646    Lithuania 1,847    Denmark 4,013    South Korea 3,034    Slovenia 3,662    Latvia 1,221    Laos 1,401    China 31    New Zealand 200    Australia 1,302   

Pfizer and BioNTech ask EU to clear vaccine for 12 to 15-year-olds

Christian Fernsby |
Pfizer and BioNTech have submitted a request for European Union drug regulators to extend the approval of the companies’ coronavirus vaccine to include children aged 12 to 15.

Article continues below




In a statement on Friday, the two companies said their submission to the European Medicines Agency (EMA) was based on an advanced study in more than 2,000 adolescents that showed the vaccine to be safe and effective.

The children will continue to be monitored for longer-term protection and safety for another two years.

The move could offer younger and less at-risk populations in Europe access to the jabs for the first time.

BioNTech and Pfizer had previously requested their emergency use authorisation with the US Food and Drug Administration to be extended to children aged 12-15.


What to read next

Pfizer says kids 12 to 15 respond great to vaccine
Coronavirus jab to be rolled out in UK from next week
FDA issues emergency use authorization for first U.S. coronavirus vaccine